Advances in Phage Therapy Offer Hope Against Superbugs
TL;DR
Researchers at VUB have developed genetically modified bacteriophages that deliver bacterial toxins to specifically target and kill multidrug-resistant E. coli, offering a promising alternative to traditional antibiotics in combating resistant bacterial infections.
Topics:healthscience#antibiotic-resistance#bacterial-toxins#bacteriophages#e-coli#genetic-engineering#science
- Genetically modified phages deliver bacterial toxins to combat multidrug-resistant E. coli Phys.org
- Stillwater researchers see positive results against ‘nightmare’ bacteria The Journal Record
- Phage Therapy Market expected to Witness Huge Revenue Growth to 2034 openPR.com
- This regulatory shift is unlocking alternatives to antibiotics in the fight against superbugs The World Economic Forum
- Professor Anton Peleg on Phage Therapy Australian Broadcasting Corporation
Want the full story? Read the original reporting
Read on Phys.org